Analytical Data
-
基因名
DERP1
- Application
-
别名
Allergen Der p I Major mite fecal allergen Der p 1 Allergen: Der p 1
-
种属
Dermatophagoides pteronyssinus
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P08176
-
表达区间
99-320aa
-
分子量
38.0 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DERP1 (Dermatology-Related Protein 1) is an intriguing protein that has garnered attention in recent years due to its potential role in skin-related conditions and immune responses. Initially identified through genomic studies, DERP1 is believed to play a significant role in the pathophysiology of various dermatological disorders, including atopic dermatitis and psoriasis. Researchers have been particularly interested in understanding the molecular mechanisms through which DERP1 influences skin inflammation and barrier function. The recombinant expression of DERP1 allows for a detailed investigation of its structure-function relationships, interactions with other cellular proteins, and its impact on immune signaling pathways. Additionally, studying DERP1 as a recombinant protein offers opportunities for therapeutic development, as it may serve as a biomarker for skin diseases or a target for novel treatments. Understanding the role of DERP1 through recombinant protein studies could pave the way for innovative strategies to manage and treat skin disorders, ultimately improving patient outcomes in dermatology.
